Certified by Founder Lodge
Mendra
United States - San Francisco
START UP
1 Disclosed Funding Rounds $82,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Therapeutics for Rare Disease Enabled by AI
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 23 ,2026 | Series A | $82,000,000 |
5AM Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)
